Navigation Links
MEDIA INVITED: Immunomic Therapeutics, Inc., Talks Vital Vaccine Technology Advancement at Biotech Showcase 2016

HERSHEY, Pa. and ROCKVILLE, Md., Jan. 12, 2016 /PRNewswire/ -- Following one of the largest upfront payments for rights to an early-stage allergy vaccine technology, Immunomic Therapeutics, Inc. (ITI) will share the projections for their potentially game-changing DNA vaccine platform with investors at the Biotech Showcase™ 2016 on Wednesday.

The talk will focus on the LAMP-vax™ platform, a unique vaccine technology that relies on the body's own natural biochemistry to increase vaccine effectiveness. Late last year, the Japanese firm, Astellas Pharma purchased the rights to apply LAMP-vax to human allergy worldwide for $300M. Astellas is working to produce a pipeline of allergy therapies, including a LAMP-vax based vaccine for peanut allergy, and ITI is now taking aim at cancer immunology. On Wednesday, ITI's Chief Financial Officer, Eric Winzer, will share LAMP-vax development plans and discuss anticipated implications on the future healthcare landscape.Who:Eric Winzer, CFO, Immunomic Therapeutics, Inc. What: 

Biotech Showcase 2016: LAMP-vax Vaccines, Next Generation ImmunotherapiesWhen: 11:45 a.m. on Wed., Jan. 13, 2016Where: 

E-Davidson, Fourth FloorParc 5555 Cyril Magnin StreetSan Francisco, CA 94102


About LAMP-vax platform

The LAMP-vax platform is a breakthrough technology that has the potential to fundamentally improve the use of vaccines across a wide variety of diseases.  LAMP-vax is a next-generation DNA vaccine that stimulates an immune response against a particular protein by injecting the DNA encoding the protein rather than the protein itself.  However, unlike older, conventional DNA vaccines, LAMP-vax includes the DNA sequence encoding Lysosomal Associated Membrane Protein (LAMP).  This allows DNA vaccines developed, based on the LAMP-vax platform, to utilize the body's natural biochemistry to develop a more complete immune response compared to conventional DNA vaccines.  Unlike conventional DNA vaccines that primarily elicit a cytotoxic T cell immune response, vaccines developed using LAMP-vax initiate a more complete immune response, including antibody production, cytokine release and critical immunological memory.  The ability to activate a complete immune response gives LAMP-vax technology potential across a number of diseases, including cancer immunotherapy, allergy and infectious diseases.

About Immunomic Therapeutics
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company dedicated to pioneering vaccines that transform lives.  Headquartered in Hershey, PA with lab facilities in Rockville, MD, ITI is developing next-generation vaccines based on patented LAMP Technology.  Its LAMP-vax vaccine platform significantly increases the immune response to nucleic acid vaccines and simplifies vaccine design and delivery for safer, more cost-effective therapies.  LAMP constructs have been validated in human clinical trials for cancer and have been applied to targets like allergy, cancer and infectious diseases.  Immunomic Therapeutics' vision is to have regulatory approved products in pollen allergy, food allergy, cancer, and animal health. For information about Immunomic Therapeutics and LAMP Technology, visit


SOURCE Immunomic Therapeutics, Inc.
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. Survey Shows That One Third Of Women (Ages 20 to 39) Polled Have Removed A Photo From Social Media To Hide Their Acne(1)
2. Dario Diabetes Management Solution Garners Global Media Coverage
3. New Study Outlines how Pharmaceutical Industry Can Boost Performance through Social Media Listening Programs
4. Allergan Reaches Settlement with New York Attorney Generals Office in Memantine Immediate Release Litigation
5. Report: Rapid Rise in Cost of Specialty Drugs Exceeds Median Family Income
6. Global and China Contrast Media / Contrast Agent Market Projections for 2015 - 2020
7. SST Group to show HIPAA/HITECH compliant DVM-EZ DICOM Virtual Media Creator for distribution of patient images and results at RSNA, booth 3254
8. Media Reports Mischaracterize Specialty Pharmacies
9. NuGene International, Inc. Files Provisional Patent Applications to Enhance Wound Treatment by Combining Micro-Current Electro-Active Dressings with Human Adipose-Derived Stem Cell Media
10. U.S. Diaphragm Pacing Study in ALS Continues Enrollment: The Post Approval Studys (PAS) Interim Data Showed Device Safety and Median Survival Post-Implant of 20.9 months
11. Contrast Media Injector Market - Global Market Research 2015-2019 - Reportlinker Review
Post Your Comments:
(Date:9/17/2019)... ... 2019 , ... Uniform Advantage (UA), a leader in the apparel ... Cancer programs and services. , This year, more than 271,000 Americans will be diagnosed ... month of October 2019, Uniform Advantage will donate $5 for every unique use of ...
(Date:9/17/2019)... WALTHAM, Mass. (PRWEB) , ... September 17, 2019 ... ... the long-term care industry, announces today the launch of RegistryConnect , the ... the input of registry owners. RegistryConnect includes care-matching, schedule recording, client and caregiver ...
(Date:9/17/2019)... ... 2019 , ... Scientists writing in a 2017 issue of ... progressive destruction of joint cartilage in osteoarthritis are “on the close horizon.” ... orthopedic surgeon Alejandro Badia, MD , founder and chief medical officer of ...
Breaking Medicine Technology:
(Date:9/22/2019)... ... September 21, 2019 , ... Dr. Perry ... certified by the American Academy of Facial Esthetics (AAFE) to administer dermal filler ... products. , Dr. Patel has also been certified by the AAFE to administer ...
(Date:9/22/2019)... Ala. (PRWEB) , ... September 22, 2019 , ... On ... drugs, according to the Centers for Disease Control and Prevention. The Baldwin County Community ... incinerator -- on Monday, Sept. 23, at 10 a.m. at the Daphne Police Department ...
(Date:9/18/2019)... ... September 18, 2019 , ... DOROT hosts its annual Rosh Hashanah Package delivery on Sunday, ... 700 volunteers will be heading out to visit our seniors. , , ... Upper East Side, at Central Synagogue 123 East 55st Street , & Westchester ...
(Date:9/18/2019)... ... September 18, 2019 , ... NJ Top Dentists has reviewed ... specializes in general and cosmetic dentistry at his practice located in Matawan, New ... quality dental care over the past seven decades. , Services provided by Dr. ...
(Date:9/17/2019)... ... September 17, 2019 , ... National University ... the American Heart Association (AHA)-San Diego Chapter to raise awareness of heart health. ... on Saturday, September 21 in Balboa Park alongside National University System Chancellor and ...
Breaking Medicine News(10 mins):